Athos Capital’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Athos Capital’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-15,000	Closed	-$1.39M	–	143
2021 Q4	$1.39M	Buy	+15,000	New	+$988K	0.44%	65

Athos Capital's ARNA Position: Q1 2022 in Review

Athos Capital sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 15,000 shares — an estimated $1.39M sold.

Athos Capital first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $1.39M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Athos Capital reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Athos Capital sold 15,000 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $1.39M.
Athos Capital first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
Athos Capital's Arena Pharmaceuticals Inc position peaked at $1.39M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Athos Capital's 13F filing for Q1 2022, filed 12 May 2022.